Skip to main content
A Singapore Government Agency Website How to identify
Official website links end with .gov.sg
Secure websites use HTTPS
Look for a lock () or https:// as an added precaution. Share sensitive information only on official, secure websites.
Government officials will never ask you to transfer money or disclose bank log-in details over a phone call.

Call the 24/7 ScamShield Helpline at 1799 if you are unsure if something is a scam.

Agency for Care Effectiveness
Published

Type 2 diabetes mellitus — personalising management with non-insulin medications ACG

Condition

Endocrine and metabolic

Guidance type

ACG

17 May 2023

Published on 17 May 2023
Last Updated on 17 May 2023

This ACE Clinical Guideline (ACG) focuses on optimising management of type 2 diabetes mellitus (T2DM) by personalising selection of non-insulin T2DM medications based on patient comorbidities and risk factors, in particular cardiovascular and renal factors.

This ACG replaces the 2017 ACG “Oral glucose-lowering agents in type 2 diabetes mellitus – an update”.

Download the ACG

T2DM – personalising management [PDF] (opens in new tab)

Or click the link below for the web version

T2DM – personalising management [WEB]

Request for a hardcopy

Click here (opens in new tab)

Registered doctors, pharmacists and nurses may claim 1 Continuing Medical Education (CME)/Continuing Professional Education (CPE) point under category 3A/ category V-B for reading each ACG.

ACG Recommendations

  1. Assess the patient’s glycaemic control and risk of adverse cardiorenal outcomes.

  2. Select and adjust T2DM medication(s) based on the patient’s glycaemic control and their risk of adverse cardiorenal outcomes.

  3. Consider metformin as first-line T2DM medication.

  4. Consider prescribing an SGLT2 inhibitor or GLP-1 RA for patients with T2DM who need to reduce their risk of adverse cardiorenal outcomes.

  5. Adopt a patient-centred approach to make shared decisions on T2DM management.

  6. Educate patients with T2DM on sustained lifestyle intervention, medication adherence, and regular review.

  7. Review all patients with T2DM regularly, including treatment response and complication screening.

ACG references and useful resources

Click below to see the list of references for the type 2 diabetes mellitus ACG and useful resources.

Feedback

Click here (opens in new tab) to give us feedback on this ACG.

Related ACGs
Other related resources